CervoMed Inc.
CRVO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001053691
No open-market purchases or sales by CervoMed Inc. insiders were filed in the last 90 days; 37 institutions reported holding it in 13F filings for Q2 2026, worth $5.42M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in CervoMed Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 13
- +2 vs. Q3 2022
- Shares held
- 182.5K
- −4.92K (−2.6%) vs. Q3 2022
- Total value
- $923.7K
- −$79.3K (−7.9%) vs. Q3 2022
- New holders
- 2
- 2 more added
- Sold out
- 0
- 3 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CRVO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 37 | $5.42M |
| Q1 2026 | 36 | $6.97M |
| Q4 2025 | 48 | $17.4M |
| Q3 2025 | 45 | $17.3M |
| Q2 2025 | 45 | $13.7M |
| Q1 2025 | 48 | $20.9M |
| Q4 2024 | 49 | $3.46M |
| Q3 2024 | 50 | $51.2M |
| Q2 2024 | 38 | $59.0M |
| Q1 2024 | 20 | $58.6M |
| Q4 2023 | 12 | $2.48M |
| Q3 2023 | 12 | $1.68M |
| Q2 2023 | 11 | $589.9K |
| Q1 2023 | 12 | $838.9K |
| Q4 2022 | 13 | $923.7K |
| Q3 2022 | 12 | $1.00M |
| Q2 2022 | 15 | $1.39M |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding CervoMed Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Connective Capital Management, LLC | 1 | $5 | 0.00% | +1 | New |
| Bank of America Corp | 4 | $20 | 0.00% | +4 | New |
| Coastal Capital Group, Inc. | 9 | $48 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 126 | $637 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 323 | $1.63K | 0.00% | −533−62.3% | Reduced |
| Morgan Stanley | 548 | $2.77K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 600 | $3.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 2,808 | $14.0K | 0.00% | +810+40.5% | Added |
| Bridgeway Capital Management, LLC | 16,565 | $84.5K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 17,123 | $87.0K | 0.00% | −42−0.2% | Reduced |
| BlackRock Inc. | 32,852 | $166.1K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 38,809 | $196.0K | 0.00% | −5,200−11.8% | Reduced |
| Vanguard Group Inc | 72,763 | $368.0K | 0.00% | +42+0.1% | Added |
| Strategic Asset Management, LLC | – | – | – | – | Not filed |